Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CACI International heads into its October 15 results with the stock rebounding from last week's lows, short interest still elevated, and a cleaner split between bulls and bears than almost any other name in defense IT.
The stock closed at $610.65 on October 9, up nearly 2% on the day but still down about 0.7% on the week. That follows the sharp drop triggered by the BNP Paribas downgrade on October 6. Short interest recovered from a one-day dip and remains around 4.2% of the free float, up roughly 10% over the past week from its late-September lows. The borrow market shows no sign of stress: availability is exceptionally loose at more than 1,300% of shares short, and the cost to borrow has eased to 0.40%, down nearly 19% on the week. Options positioning is skewed firmly toward calls. The put/call ratio of 0.27 is near its 52-week low, below its 20-day average of 0.30, and well off the 0.39 range that prevailed through August and September. Taken together, the lending and options data describe a market leaning long rather than braced for a miss.
The analyst debate is the more pointed question heading into the print. BNP Paribas's downgrade to Underperform with a $540 target sits more than 11% below where the stock trades today, and it crystallises the bear case: CACI's FQ2 revenue missed expectations, the book-to-bill ratio came in at a weak 0.6x, and the funded backlog has been shrinking. Federal budget uncertainty, staffing costs, and competitive pricing are the structural concerns behind the negative view. Against that, Citigroup raised its Neutral target to $689 on October 7, and the post-August upgrades from JP Morgan (Overweight, $715) and UBS (Buy, $804) reflect a different read: the company raised full-year revenue guidance to $9.3 to $9.5 billion, implying 8 to 10% growth, and free cash flow generation has been strong. The mean analyst target of $729 implies around 19% upside from the current price, though that consensus average includes a wide spread of views.
One institutional move worth noting: Barrow, Hanley, Mewhinney & Strauss added 692,255 shares as of July 31, lifting its stake to 4.3% of shares outstanding. That is a material build for a name of CACI's size and reflects a conviction bet made ahead of the August results. BlackRock, the largest holder at 9.9% of shares, added 88,940 shares through September. The pattern among major holders is broadly constructive, even as the stock has drifted back from its August highs. The last earnings print produced a one-day move of around 24%, so the reaction function on this stock is well established as capable of sharp swings in either direction.
Thursday's report is therefore a test of whether the August re-rating was justified by a durable improvement in contract awards, or whether the weak book-to-bill that concerned BNP Paribas signals a more persistent slowdown in new business formation.
See the live data behind this article on ORTEX.
Open CACI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
